J9267
J9267 – Injection, paclitaxel, 1 mg · NDC Crosswalk & Billing Units
HCPCS Level II J-code · Medicare Part B drug billing
J-code
● 43 NDCs crosswalked per 1 MG $0.112/unit ASP+6%
📋 J9267 summary
J9267 is a HCPCS Level II J-code used to bill paclitaxel, 1 mg, billed per 1 MG. The number of billing units to report depends on the dose administered and the NDC/package billed — use the calculator below.
Brand names associated with J9267: Paclitaxel Paclitaxel
Code J9267
Billing unit 1 MG Payment limit $0.112/unit NDC-Crosswalk 43
Quarter Q3 2026
RxCUI Atlas Trace the drug concept →
⚠ An NDC↔HCPCS crosswalk and a published payment limit do not guarantee payer coverage or payment. Always verify the current payer policy and claim format before billing.
🗂️ Key billing facts
HCPCS codeJ9267
DescriptorInjection, paclitaxel, 1 mg
Billing unit1 MG
Payment limit / unit$0.112
Est. ASP / unit$0.106 est.
Mapped NDCs43
Data periodQ3 2026
Last updated2026-08-20
💊 About Paclitaxel DRUG GUIDE
Paclitaxel injection (solution form) is used for advanced ovarian cancer, node-positive breast cancer (as adjuvant therapy), metastatic breast cancer, non-small cell lung cancer (in combination with cisplatin), and AIDS-related Kaposi's sarcoma as a second-line treatment.Paclitaxel protein-bound particles for injectable suspension (albumin-bound) — sold as Abraxane and related products — is approved for metastatic breast cancer after prior chemotherapy, locally advanced or metastatic non-small cell lung cancer (in combination with carboplatin) as first-line treatment, and metastatic adenocarcinoma of the pancreas (in combination with gemcitabine) as first-line treatment.
These albumin-bound products are not interchangeable with other paclitaxel formulations.
Clinical overview from our editorial drug guide for Paclitaxel. For billing reference, see the sections above.
🧾 Billing & reimbursement HCPCS · CMS · EFF. Q3 2026
📅 Payment limits effective Q3 2026 — from the CMS Medicare Part B Payment Limit File (revised quarterly).
Medicare payment limit / unit
$0.112
Est. ASP / unit
$0.106 est.
Est. after 2% sequester
$0.110
HCPCS dosage
1 MG
The CMS payment limit is the Medicare Part B drug allowance (ASP + 6%, statutory). After the 2% federal sequester the effective payment is ≈ ASP + 4.3%; estimated ASP = payment limit ÷ 1.06. Source: CMS Medicare Part B Payment Limit File (quarterly), Q3 2026.
Full HCPCS code details (official CMS record)
Long descriptionInjection, paclitaxel, 1 mg
CoverageD — Special coverage instructions apply
Pricing indicator51 — Drug — priced under the ASP methodology
Type of service1 — Medical care
BETOS-2O1D
ASC payment group—
Action codeN — No maintenance this year
Effective date2015-01-01
Date added2015-01-01
Source: CMS HCPCS Level II code file (imported via admin).
🧮 Dosing & billing-units calculator HCPCS UNITS
One billing unit of J9267 = 1 mg. Enter a regimen to convert dose → billing units and project a full course.
Billing units = dose ÷ HCPCS unit size. Most payers require whole units — round per the payer's policy. “Est. Medicare pay” uses the current payment limit. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (JZ when none is discarded) where allowed. Always verify payer-specific rounding before billing.
🔁 NDCs that bill under J9267 WITH EST. MEDICARE PAY
43 NDCs map to J9267. Bill units = how many HCPCS units one package represents. Est. pay / pkg = payment limit ($0.112/unit) × that package's bill units.
| NDC (11-digit) | Drug | Labeler | Package | Strength | Bill units | Est. pay / pkg | NADAC / unit | Status | Source |
|---|---|---|---|---|---|---|---|---|---|
| 00703-3213-01 | Paclitaxel 6 mg/mL INJECTION, SOLUTION, CONCENTRATE | Teva | 1 VIAL, MULTI-DOSE in 1 CARTON (0703-3213-... | 6 mg/mL | 30 | $3.36 | — | ● Active | CMS + PDAC |
| 00703-3213-81 | Paclitaxel 6 mg/mL INJECTION, SOLUTION, CONCENTRATE | Teva | 1 VIAL, MULTI-DOSE in 1 CARTON (0703-3213-... | 6 mg/mL | 30 | $3.36 | — | ● Active | CMS + PDAC |
| 00703-3216-01 | Paclitaxel 6 mg/mL INJECTION, SOLUTION, CONCENTRATE | Teva | 1 VIAL, MULTI-DOSE in 1 CARTON (0703-3216-... | 6 mg/mL | 100 | $11.20 | — | ● Active | CMS + PDAC |
| 00703-3216-81 | Paclitaxel 6 mg/mL INJECTION, SOLUTION, CONCENTRATE | Teva | 1 VIAL, MULTI-DOSE in 1 CARTON (0703-3216-... | 6 mg/mL | 100 | $11.20 | — | ● Active | CMS + PDAC |
| 00703-3217-01 | Paclitaxel 6 mg/mL INJECTION, SOLUTION, CONCENTRATE | Teva | 1 VIAL, MULTI-DOSE in 1 CARTON (0703-3217-... | 6 mg/mL | 150 | $16.80 | — | ● Active | CMS + PDAC |
| 00703-3218-01 | Paclitaxel 6 mg/mL INJECTION, SOLUTION, CONCENTRATE | Teva | 1 VIAL, MULTI-DOSE in 1 CARTON (0703-3218-... | 6 mg/mL | 300 | $33.60 | — | ● Active | CMS + PDAC |
| 00703-3218-81 | Paclitaxel 6 mg/mL INJECTION, SOLUTION, CONCENTRATE | Teva | 1 VIAL, MULTI-DOSE in 1 CARTON (0703-3218-... | 6 mg/mL | 300 | $33.60 | — | ● Active | CMS + PDAC |
| 16714-0137-01 | Paclitaxel 6 mg/mL INJECTION, SOLUTION | Northstar | 1 VIAL, MULTI-DOSE in 1 CARTON (16714-137-... | 6 mg/mL | 300 | $33.60 | — | ● Active | CMS + PDAC |
| 23155-0882-31 | PACLITAXEL 6 mg/mL INJECTION, SOLUTION | Heritage | 1 VIAL, MULTI-DOSE in 1 CARTON (23155-882-... | 6 mg/mL | 30 | $3.36 | — | ● Active | CMS + PDAC |
| 23155-0883-31 | PACLITAXEL 6 mg/mL INJECTION, SOLUTION | Heritage | 1 VIAL, MULTI-DOSE in 1 CARTON (23155-883-... | 6 mg/mL | 100 | $11.20 | — | ● Active | CMS + PDAC |
| 23155-0884-31 | PACLITAXEL 6 mg/mL INJECTION, SOLUTION | Heritage | 1 VIAL, MULTI-DOSE in 1 CARTON (23155-884-... | 6 mg/mL | 300 | $33.60 | — | ● Active | CMS + PDAC |
| 25021-0255-05 | Paclitaxel 6 mg/mL INJECTION, SOLUTION | Sagent | 1 VIAL in 1 CARTON (25021-255-05) / 5 mL... | 6 mg/mL | 30 | $3.36 | — | ● Active | CMS + PDAC |
| 25021-0255-17 | Paclitaxel 6 mg/mL INJECTION, SOLUTION | Sagent | 1 VIAL in 1 CARTON (25021-255-17) / 16.7... | 6 mg/mL | 100 | $11.20 | — | ● Active | CMS + PDAC |
| 25021-0255-50 | Paclitaxel 6 mg/mL INJECTION, SOLUTION | Sagent | 1 VIAL in 1 CARTON (25021-255-50) / 50 mL... | 6 mg/mL | 300 | $33.60 | — | ● Active | CMS + PDAC |
| 61703-0015-04 | Paclitaxel 6 mg/mL INJECTION, SOLUTION | Hospira, | 1 VIAL, MULTI-DOSE in 1 CARTON (61703-015-... | 6 mg/mL | 30 | $3.36 | — | ● Active | CMS + PDAC |
| 61703-0342-09 | Paclitaxel 6 mg/mL INJECTION, SOLUTION | Hospira, | 1 VIAL, MULTI-DOSE in 1 CARTON (61703-342-... | 6 mg/mL | 30 | $3.36 | — | ● Active | CMS + PDAC |
| 61703-0342-22 | Paclitaxel 6 mg/mL INJECTION, SOLUTION | Hospira, | 1 VIAL, MULTI-DOSE in 1 CARTON (61703-342-... | 6 mg/mL | 100 | $11.20 | — | ● Active | CMS + PDAC |
| 61703-0342-50 | Paclitaxel 6 mg/mL INJECTION, SOLUTION | Hospira, | 1 VIAL, MULTI-DOSE in 1 CARTON (61703-342-... | 6 mg/mL | 300 | $33.60 | — | ● Active | CMS + PDAC |
| 62332-0620-05 | Paclitaxel 6 mg/mL INJECTION | Alembic | 1 VIAL, MULTI-DOSE in 1 CARTON (62332-620-... | 6 mg/mL | 30 | $3.36 | — | ● Active | CMS + PDAC |
| 62332-0621-17 | Paclitaxel 6 mg/mL INJECTION | Alembic | 1 VIAL, MULTI-DOSE in 1 CARTON (62332-621-... | 6 mg/mL | 100 | $11.20 | — | ● Active | CMS + PDAC |
| 62332-0622-50 | Paclitaxel 6 mg/mL INJECTION | Alembic | 1 VIAL, MULTI-DOSE in 1 CARTON (62332-622-... | 6 mg/mL | 300 | $33.60 | — | ● Active | CMS + PDAC |
| 63323-0763-16 | Paclitaxel 6 mg/mL INJECTION, SOLUTION | Fresenius | 1 VIAL, MULTI-DOSE in 1 CARTON (63323-763-... | 6 mg/mL | 100 | $11.20 | — | ● Active | CMS ASP |
| 63323-0763-50 | Paclitaxel 6 mg/mL INJECTION, SOLUTION | Fresenius | 1 VIAL, MULTI-DOSE in 1 CARTON (63323-763-... | 6 mg/mL | 300 | $33.60 | — | ● Active | CMS ASP |
| 68001-0516-27 | Paclitaxel 6 mg/mL INJECTION, SOLUTION | BluePoint | 1 VIAL, MULTI-DOSE in 1 CARTON (68001-516-... | 6 mg/mL | 300 | $33.60 | — | ● Active | CMS + PDAC |
| 70860-0200-05 | Paclitaxel | Athenex | — | — | 30 | $3.36 | — | — | CMS + PDAC |
| 70860-0200-17 | Paclitaxel | Athenex | — | — | 100 | $11.20 | — | — | CMS + PDAC |
| 70860-0200-50 | Paclitaxel | Athenex | — | — | 300 | $33.60 | — | — | CMS + PDAC |
| 70860-0215-66 | Paclitaxel | Athenex | — | — | 30 | $3.36 | — | — | CMS ASP |
| 70860-0215-67 | Paclitaxel | Athenex | — | — | 100 | $11.20 | — | — | CMS ASP |
| 70860-0215-68 | Paclitaxel | Athenex | — | — | 300 | $33.60 | — | — | CMS + PDAC |
| 72205-0063-01 | Paclitaxel 6 mg/mL INJECTION, SOLUTION | Novadoz | 1 VIAL, MULTI-DOSE in 1 CARTON (72205-063-... | 6 mg/mL | 300 | $33.60 | — | ● Active | CMS + PDAC |
| 72205-0062-01 | Paclitaxel 6 mg/mL INJECTION, SOLUTION | Novadoz | 1 VIAL, MULTI-DOSE in 1 CARTON (72205-062-... | 6 mg/mL | 6 | $0.67 | — | ● Active | PDAC |
| 72205-0061-01 | Paclitaxel 6 mg/mL INJECTION, SOLUTION | Novadoz | 1 VIAL, MULTI-DOSE in 1 CARTON (72205-061-... | 6 mg/mL | 6 | $0.67 | — | ● Active | PDAC |
| 45963-0613-83 | PREMIERPRO RX PACLITAXEL (LATEX-FREE) 6 MG/1 ML | Unknown | — | — | 6 | $0.67 | — | — | PDAC |
| 45963-0613-89 | PREMIERPRO RX PACLITAXEL (PF,LATEX-FREE) 6 MG/1 ML | Unknown | — | — | 6 | $0.67 | — | — | PDAC |
| 45963-0613-86 | PREMIERPRO RX PACLITAXEL (PF,LATEX-FREE) 6 MG/1 ML | Unknown | — | — | 6 | $0.67 | — | — | PDAC |
| 47781-0595-07 | PACLITAXEL (MDV,PF,LATEX-FREE) 6 MG/1 ML | Unknown | — | — | 6 | $0.67 | — | — | PDAC |
| 47781-0594-07 | PACLITAXEL (MDV,PF,LATEX-FREE) 6 MG/1 ML | Unknown | — | — | 6 | $0.67 | — | — | PDAC |
| 47781-0593-07 | PACLITAXEL (MDV,PF,LATEX-FREE) 6 MG/1 ML | Unknown | — | — | 6 | $0.67 | — | — | PDAC |
| 45963-0613-59 | PACLITAXEL (MDV,PF) 6 MG/1 ML | Unknown | — | — | 6 | $0.67 | — | — | PDAC |
| 67457-0434-51 | PACLITAXEL (MDV) 6 MG/ML | Unknown | — | — | 6 | $0.67 | — | — | PDAC |
| 67457-0449-17 | PACLITAXEL (MDV) 6 MG/ML | Unknown | — | — | 6 | $0.67 | — | — | PDAC |
| 67457-0471-52 | PACLITAXEL (MDV) 6 MG/ML | Unknown | — | — | 6 | $0.67 | — | — | PDAC |
NDC→HCPCS mappings come from the CMS ASP NDC-HCPCS crosswalk; additional DME MAC / DMEPOS mappings come from PDAC and are labeled separately. NADAC from CMS (weekly). “Status” reflects the product's marketing / obsolete flag in the NDC directory. Presence or absence here does not determine Medicare coverage. Linked NDCs open the full product page.
📊 Medicare utilization & spend CMS · PART B · 2026 (Q1)
Period
Total Part B spend
$286.3K
Claims
18,259
Beneficiaries
5,244
Spend / beneficiary
$54.60
Spend / claim
$15.68
Trend by period
Where J9267 ranks among Part B drugs · 2026 (Q1) · neighbors ±5
Total spending — #495 of 824
#490
DEPO-TESTOSTERONE* J1071
$304.4K
#491
KETOROLAC TROMETHAMI... J1885
$302.9K
#492
SUBLOCADE(Q9991) Q9991
$297.3K
#493
EMEND* J1453
$297.3K
#494
XWRAP 1 SQ CM** Q4204
$288K
#495
PACLITAXEL J9267
$286.3K
#496
EDETATE CALCIUM DISO... J0600
$284.6K
#497
PYRIDOXINE HCL J3415
$283.3K
#498
TDVAX* 90714
$282.9K
#499
AMNIO QUAD-CORE, PER... Q4294
$270.2K
#500
DAXXIFY J0589
$269.7K
Total claims — #118 of 824
#113
AZACITIDINE* J9025
19,241
#114
EMEND* J1453
19,071
#115
ALBUKED-25(P9047)* P9047
18,777
#116
MONOFERRIC J1437
18,337
#117
OCTAGAM J1568
18,321
#118
PACLITAXEL J9267
18,259
#119
ENHERTU J9358
18,044
#120
CARBOPLATIN* J9045
18,010
#121
OCTREOTIDE ACETATE E... J2353
17,897
#122
LANREOTIDE ACETATE(J... J1930
17,811
#123
GEMCITABINE HCL(J920... J9201
17,649
Top Medicare Part B drugs by the selected metric. Click any drug to open its J-code page. Source: CMS Medicare Quarterly Part B Spending by Drug.
Full breakdown by period (2)
| Period | Total spend | Beneficiaries | Claims | $/beneficiary | $/claim |
|---|---|---|---|---|---|
| 2026 (Q1) | $286.3K | 5,244 | 18,259 | $54.60 | $15.68 |
| 2025 (Q1-Q4) | $1.51M | 14,134 | 80,697 | $107.11 | $18.76 |
Provider-administered (Part B) spend, calculated for the whole HCPCS code (CMS does not publish Medicare spend per individual NDC). Self-administered use is covered under Part D instead. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part B Spending by Drug (data.cms.gov), updated quarterly.
📈 Medicare Part B claims detail CMS PSPS · 2024
Calendar-year 2024 Medicare Part B fee-for-service activity for this HCPCS code, summed across all carriers, localities and specialties (CMS Physician/Supplier Procedure Summary). A “service” is one billed line/unit — not one claim — so counts run higher than claim counts.
Allowed charges
$1.55M
Medicare paid
$1.19M
Submitted services
13,562,999
Denial rate
3.9%
Allowed / service
$0.12
Submitted charges
$46.5M
Source: CMS Physician/Supplier Procedure Summary (PSPS), CY2024 — Medicare Part B carrier + DME fee-for-service claims (excludes Medicare Advantage). Figures are for the whole HCPCS code, which may cover uses beyond this drug. ⚠ CMS hides any figure covering fewer than 11 patients (a privacy rule), so totals — especially denials and low-volume codes — run a little low.
🗺️ Where J9267 is utilized CMS · BY PROVIDER · 2024
Medicare Part B services for this code by the rendering provider's state — 7,030,641 services across 42 states & territories in 2024 (CMS reports include DC and U.S. territories). Switch to per 100k to compare states fairly regardless of population. Hover or tap a state for its top ZIP codes.
Hover or tap a state to see its numbers + top ZIP codes.
Per-capita = services ÷ 2023 state population × 100,000 (so high-population states aren't automatically "hotter"). Counts reflect the provider's location, not the patient's. Providers with fewer than 11 patients are hidden by CMS for privacy, so totals run low and per-100k can be noisy in small states — read this as relative geography, not exact counts. Source: CMS Medicare Physician & Other Practitioners — by Provider and Service, 2024.
📊 What bills under J9267
J-codes are billing codes often used for drugs billed under the medical benefit. This connects the billing code to the NDC package records it covers, by ingredient and labeler.
NDC products by ingredient
NDC products by labeler
🗃️ Data sources & freshness
Every figure on this page is computed from public datasets. Here's what each section draws on and how current it is.
HCPCS code & descriptor
CMS HCPCS Level II code file
Loaded
Payment limit & billing unit
CMS Medicare Part B ASP Pricing File (quarterly)
Q3 2026 · as of 2026-08-20
NDC ↔ HCPCS crosswalk
CMS ASP NDC-HCPCS crosswalk + DMEPDAC (PDAC)
43 NDCs mapped
NADAC acquisition cost
CMS National Average Drug Acquisition Cost (weekly)
Not available for mapped NDCs
Utilization & spend
CMS Part B Spending by Drug · PSPS · Physician & Other Practitioners
Latest data year 2026
Figures are estimates for reference and may lag the source files. Always verify against the current CMS files and your payer's policy before submitting claims.
⚠️ Practical billing caveats
- A crosswalk is not coverage. An NDC mapping or a published payment limit does not guarantee a payer will cover or pay this code. Check the specific plan's policy.
- Units ≠ milligrams. Bill the number of HCPCS units (dose ÷ the code's unit size), not the milligram dose. Use the calculator above.
- Discarded drug. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (and JZ when nothing is discarded) where the payer allows.
- Rounding & partial units. Many payers require whole units; round per the payer's policy, not automatically up.
- The code can cover more than this drug. Some HCPCS codes span multiple products or strengths — confirm the exact code for the product administered.
- Figures lag. ASP limits change quarterly and utilization data are released with a delay. Verify against the current CMS files before billing.
❓ J9267 billing FAQ
What is HCPCS code J9267?
J9267 is a HCPCS Level II J-code used to bill Injection, paclitaxel, 1 mg under Medicare Part B and most medical (not pharmacy) benefits.
What is the billing unit for J9267?
One unit of J9267 represents 1 MG. Report the number of units equal to the dose administered divided by 1 MG.
How many units of J9267 should I bill?
Divide the dose administered by the code's unit size (1 MG) to get the number of billing units, then round per your payer's policy. The calculator on this page converts a dose into billing units and projects a full course.
How much does Medicare pay for J9267?
The Medicare Part B payment limit is $0.112 per unit (Q3 2026), based on ASP + 6%. After the 2% sequester the effective payment is about $0.110 per unit. Payment limits are revised quarterly.
Which NDCs bill under J9267?
43 NDCs currently map to J9267 in the CMS ASP NDC-HCPCS crosswalk. See the NDC crosswalk table above for each product, package, billing units and estimated reimbursement.
Does a crosswalk mean J9267 is covered?
No. An NDC-to-HCPCS crosswalk and a published payment limit do not guarantee coverage or payment. Coverage depends on the payer, the diagnosis and the site of care — always verify the current policy before billing.
For professional billing reference only — verify against the current CMS files before submitting claims.